Elanco Animal Health Inc Quarterly Nonoperating Income (Expense) in USD from Q3 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Elanco Animal Health Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2017 to Q3 2024.
  • Elanco Animal Health Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$1M, a 88.9% increase year-over-year.
  • Elanco Animal Health Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$46M, a 25.8% increase year-over-year.
  • Elanco Animal Health Inc annual Nonoperating Income (Expense) for 2023 was -$75M, a 134% decline from 2022.
  • Elanco Animal Health Inc annual Nonoperating Income (Expense) for 2022 was -$32M, a 540% decline from 2021.
  • Elanco Animal Health Inc annual Nonoperating Income (Expense) for 2021 was -$5M, a 103% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$46M -$1M +$8M +88.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$54M -$2M +$21M +91.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$75M -$9M $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$75M -$34M -$13M -61.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 -$62M -$9M -$1M -12.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$61M -$23M -$29M -483% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$32M -$9M $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$32M -$21M -$24M -800% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 -$8M -$8M +$3M +27.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$11M $6M +$3M +100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$14M -$9M -$9M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$5M $3M -$13M -81.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $8M -$11M -$126M -110% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $134M $3M -$45M -93.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $179M $0 +$1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $178M $16M +$22.9M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $155M $115M +$130M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $25.5M $48M +$51.9M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$26.4M -$1M +$1.6M +61.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$28M -$6.9M +$18.8M +73.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$46.8M -$14.6M -$9.7M -198% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$37.1M -$3.9M +$4.9M +55.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 -$42M -$2.6M -$700K -36.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$41.3M -$25.7M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$4.9M -$6.8M -358% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$8.8M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$1.9M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q3 2017 $1.9M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.